EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth

E Bayar, D A MacIntyre, L Sykes, K Mountain, T P Parks, P P Lee, P R Bennett

Beneficial Microbes · 2023

DOI: 10.3920/bm2022.0084 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Beneficial Microbes, 2023. Verfasst von E Bayar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, W120NN London, United Kingdo…. Hauptthemen laut MEDLINE: Lactobacillus crispatus, Premature Birth, Probiotics. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The vaginal microbiota is a determinant for the risk of preterm birth (PTB). Dominance of the vaginal niche by Lactobacillus crispatus associates with term delivery. This is the first observational clinical study of live vaginal biotherapeutics ( Lactobacillus crispatus CTV-05 (LACTIN-V)) in pregnant women at high-risk of PTB. The primary aim was to explore safety, tolerability and acceptability of LACTIN-V in pregnancy. Women were offered a course of LACTIN-V at 14 weeks gestation for five consecutive days followed by weekly administration for six weeks. Participants were followed up at 15, 18-, 20-, 28- and 36-weeks’ gestation and at delivery for assessment of adverse events, compliance and tolerability. Participants completed a questionnaire to gauge experience and acceptability. In total, 73 women were recruited, of whom eight withdrew, leaving a final cohort size of 61. Self-reported compliance to the course was high (56/60, 93%). Solicited adverse events were reported in 13 women (19%) including changes in vaginal discharge, odour, colour or consistency of urine, itching and vaginal bleeding. One unsolicited adverse event was reported as haematuria at 38 weeks gestation, but was judged to be unrelated to LACTIN-V. No serious adverse events occurred. One mild adverse event led to study withdrawal. Thirty-one women completed an experience and acceptability questionnaire. Women found LACTIN-V easy and comfortable to use and the majority (30/31, 97%) would use LACTIN-V in future pregnancies. Eight women (8/31, 26%) found the schedule of use difficult to remember. The rate of PTB

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactobacillus crispatusPremature BirthProbioticsInfant, NewbornFemalePregnancyHumansPregnant PeopleVagina

Stichwörter der Autor:innen

live vaginal biotherapeuticspregnancyvaginal microbiome

Autor:innen und Institutionen

  • Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, W120NN London, United Kingdom.
  • March of Dimes European Prematurity Research Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, W120NN London, UK, United Kingdom.
  • Tommy's National Centre for Miscarriage Research. Imperial College London, Hammersmith Hospital Campus, Du Cane Road, W120NN London, United Kingdom.
  • The Parasol Foundation Centre for Women's Health and Cancer Research, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, W2 1NY.
  • Osel Inc., 320 Logue Ave # 114, Mountain View, CA 94043, USA.

Zitieren

APA

Bayar, E., MacIntyre, D. A., Sykes, L., Mountain, K., Parks, T. P., Lee, P. P., & Bennett, P. R. (2023). Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth. Beneficial Microbes. https://doi.org/10.3920/bm2022.0084

Vancouver

Bayar E, MacIntyre DA, Sykes L, Mountain K, Parks TP, Lee PP, et al. Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth. Beneficial Microbes. 2023. doi:10.3920/bm2022.0084

BibTeX
@article{Bayar2023,
  author = {Bayar, E and MacIntyre, D A and Sykes, L and Mountain, K and Parks, T P and Lee, P P and Bennett, P R},
  title = {Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth},
  journal = {Beneficial Microbes},
  year = {2023},
  doi = {10.3920/bm2022.0084}
}
Kostenlos starten →